K Number
K201239
Manufacturer
Date Cleared
2020-12-31

(238 days)

Product Code
Regulation Number
890.5850
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The NuEra Tight Family, EMS Model, is intended for:

  • improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen;
  • strengthening, toning and firming of buttocks, thighs and calves;
  • improvement of muscle tone and firmness, for strengthening muscles in arms.
Device Description

NuEra Tight Family, EMS Model, is a family of devices designed to:

  • produce an electromagnetic field that induces electrical current in the muscles. By muscle stimulation, the system helps to strengthen, tone and firm the abdomen, buttocks, thighs and calves.
    The device belonging to the NuEra Tight Family, EMS Model, generates an intense magnetic field which is used to stimulate muscles trough two EMS handpieces, one small and one large, which can treat body parts of different sizes.
AI/ML Overview

This document is a 510(k) summary for the NuEra Tight Family, EMS Model, a powered muscle stimulator. It focuses on demonstrating substantial equivalence to a predicate device rather than presenting a study proving the device meets specific acceptance criteria based on clinical outcomes.

Therefore, the requested information regarding acceptance criteria and a study proving the device meets them, especially in terms of clinical performance, cannot be fully extracted as such a study is not part of this 510(k) submission. This document primarily addresses safety, electrical compatibility, and functional equivalence to a predicate device already on the market.

However, I can extract information related to the performance data presented within the context of demonstrating substantial equivalence.

1. A table of acceptance criteria and the reported device performance

The document does not detail specific acceptance criteria for clinical efficacy or the reported performance of the device against such criteria. Instead, it focuses on demonstrating compliance with safety and technical standards and functional equivalence to a predicate device.

The performance data provided relates to:

Acceptance Criteria (Implied)Reported Device Performance
Electrical SafetyIn compliance with IEC 60601-1, IEC 60601-1-2, IEC 60601-1-6, and IEC 60601-2-10/A1.
Software Verification and ValidationSoftware verification was conducted to FDA regulations, standards, and guidance document requirements. Results conclude the software has met these requirements.
Functional Testing (Technical Specifications)Functional tests performed confirmed alignment with device technical specifications.
BiocompatibilityAssessed in accordance with ISO 10993-1:2018 and FDA guidance. The device has no contact with patient skin.
Risk ManagementIn compliance with ISO 14971.

2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)

This 510(k) summary does not describe any clinical study with a "test set" of patients or data provenance in the context of clinical performance. The testing mentioned (electrical safety, software, functional) is laboratory or engineering-based.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience)

Not applicable. This information pertains to clinical performance evaluations, which are not detailed in this 510(k) submission.

4. Adjudication method (e.g., 2+1, 3+1, none) for the test set

Not applicable, as no clinical test set requiring adjudication is described.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This device is a powered muscle stimulator, not an AI-assisted diagnostic or therapeutic tool with human readers.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Not applicable. This device is a physical medical device for muscle stimulation.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

The document does not describe clinical ground truth establishment. For the technical performance aspects:

  • Electrical Safety & EMC: Compliance with international standards (IEC 60601 series).
  • Software V&V: Compliance with FDA regulations, standards, and guidance.
  • Functional Testing: Device technical specifications served as the "ground truth" for these tests.

8. The sample size for the training set

Not applicable. This is not a machine learning or AI-driven device.

9. How the ground truth for the training set was established

Not applicable. This is not a machine learning or AI-driven device.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

December 31, 2020

Bios s.r.l. Maurizio Bianchi Head of QA/RA Via Guido Rossa 10/12 Vimodrone, MI 20090 Italy

Re: K201239

Trade/Device Name: NuEra Tight Family, EMS Model Regulation Number: 21 CFR 890.5850 Regulation Name: Powered Muscle Stimulator Regulatory Class: Class II Product Code: NGX Dated: October 5, 2020 Received: October 8, 2020

Dear Maurizio Bianchi:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

{1}------------------------------------------------

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance)and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Heather Dean, PhD Assistant Director, Acute Injury Devices Team DHT5B: Division of Neuromodulation and Physical Medicine Devices OHT5: Office of Neurological and Physical Medicine Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K201239

Device Name NuEra Tight Family, EMS Model

Indications for Use (Describe)

The NuEra Tight Family, EMS Model, is intended for:
-------------------------------------------------------
  • improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen;

  • strengthening, toning and firming of buttocks, thighs and calves;

  • improvement of muscle tone and firmness, for strengthening muscles in arms.

Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) Summary

Contact Details
510(k) NumberK201239
510(k) TypeTraditional
Applicant InformationBios s.r.l.Via Guido Rossa, 10/1220090 Vimodrone (MI) – Italy
ContactDr Eliana Russo
Date Prepared24 June 2020
Device Name(s):NuEra Tight Family, EMS Model
Model RefsAPMD151
Common NamePowered Muscle Stimulator
Regulatory ClassClass II
Product CodesNGX
Regulation NamesStimulator, muscle, powered, for muscle conditioning
Predicate Device for EMS Treatments
K190456NGX, 890.5850Powered Muscle Stimulator (BTL 799-2L)BTL Industries, Inc.

Device Description

NuEra Tight Family, EMS Model, is a family of devices designed to:

  • produce an electromagnetic field that induces electrical current in the muscles. By muscle stimulation, the system helps to strengthen, tone and firm the abdomen, buttocks, thighs and calves.
    The device belonging to the NuEra Tight Family, EMS Model, generates an intense magnetic field which is used to stimulate muscles trough two EMS handpieces, one small and one large, which can treat body parts of different sizes.

Indications for Use

The NuEra Tight Family, EMS Model, is intended for:

  • . Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen;
  • ı Strengthening, toning and firming of buttocks, thighs and calves;
  • . Improvement of muscle tone and firmness, for strengthening muscles in arms.

Predicate Device Comparison

The product specification, functionality, indications for use, and treatment parameters of the NuEra Tight Family, EMS Model, are the same or very similar to the legally marketed predicate and reference devices.

{4}------------------------------------------------

For the electromagnetic stimulation function, the subject device and predicate device have many identical, similar or substantially equivalent properties or features. No differences that could affect safety or effectiveness have been identified, as indicated in Table 1.

Table 1: Predicate device comparison table – NuEra Tight Family, EMS Model – Electromagnetic Stimulation
FeatureSubject devicePredicate deviceSimilarity
Device nameNuEra Tight Family (EMS Model)BTL 799-2LN/A
Device ManufacturerBios S.r.l.BTL Industries, Inc.N/A
510(K) NumberK201239K190456N/A
Product CodeNGX - Stimulator, Muscle, PoweredNGX - Stimulator, Muscle, PoweredSame
Regulation21 CFR 890.585021 CFR 890.5850Same
Indications for UseThe NuEra Tight Family (EMS Model) is intended:• for improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen;• for strengthening, toning and firming of buttocks, thighs and calves;• for improvement of muscle tone and firmness, for strengthening muscles in arms.BTL 799-2L is indicated to be used for:• Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen.• Strengthening, toning and firming of buttocks, thighs and calves.• Improvement of muscle tone and firmness, for strengthening muscles in arms.Same
Principle of actionInitiating action potential of nerves results in muscle contraction.Initiating action potential of nerves results in muscle contraction.Same
Clinical usePrescription UsePrescription UseSame
Electrical ProtectionClass I type BFClass I type BFSame
User InterfaceTouch ScreenTouch ScreenSame
Firmware ControlledYesYesSame
Type of energyMagnetic FieldMagnetic FieldSame
Number of outputs22Same
Number of magneticcoils in the applicator11Same
Magnetic Field IntensityLarge HP: 0.5 – 1.8 T ± 20%BTL 299-6 applicator: 0.5 - 1.8 T ± 20%Same
Small HP: 0.7 – 2.0 T ± 20%BTL 299-7 applicator: 0.7 - 2.0 T ± 20%Same
Pulse Repetition Rate1-150 Hz1-150 HzSame
Pulse DurationLarge HP: 280 ± 20% µsBTL 299-6 applicator: 280 ± 20% µsSame
Small HP: 190 ± 20% µsBTL 299-7 applicator: 190 ± 20% µsSame
Therapy TimeUp to 60 minUp to 60 minSame
CharacteristicsBios DevicePredicate DeviceNotes
Device nameNuEra Tight Family (EMS Model)BTL 799-2LN/A
Device ManufacturerBios s.r.l.BTL Industries, Inc.N/A
510(K) NumberK201239K190456N/A
Power Source(s)- Method of LineCurrent IsolationPatient LeakageCurrent- Normal condition- Single fault conditionIEC 60601-1 compliant< 0,1 μΑ< 5 μΑIEC 60601-1 compliant< 0,1 μΑ< 5 μΑN/A
Average DC currentthrough electrodeswhen device is on butno pulses are beingapplied (µA)N/AN/ANo electrodes.Applicators arenot connectedto patient.
Number of OutputModes11N/A
Number of OutputChannels- Synchronous orAlternating?2Synchronous2SynchronousNo electrodes.Applicators arenot connectedto patient.
- Method of ChannelIsolationN/AN/A
Regulated Current orRegulated Voltage?Regulated voltageRegulated VoltageN/A
Software /Firmware/MicroprocessorControl?YesYesN/A
Automatic OverloadTrip?N/AN/ANo electrodes.Applicators arenot connectedto patient.
Automatic No-LoadTrip?N/AN/ANo electrodes.Applicators arenot connectedto patient.
Automatic Shut Off?NoNot availableN/A
Patient OverrideControl?YesNot availableN/A
Indicator Display:- On/Off Status?- Low Battery?- Voltage/CurrentLevel?YesN/ANoYesN/ANoN/A
Timer Range (minutes)Up to 30 minutesUp to 30 minutesN/A
Compliance withVoluntary Standards?(If yes, specify) (If yes,specify)N/AN/AN/A
Compliancewith 21 CFR 898?N/AN/AN/A
Weight100 kgNot availableN/A
Dimensions (in.) [W xH x D]1350x560x710 mm(53x22x28 in)580x1380x580 mm (23x55x23 in)N/A
Housing Materials andConstructionSteel and Injection MoldedPlasticsSteel and Injection Molded PlasticsN/A

{5}------------------------------------------------

Table 2: Basic Unit Characteristics

This section is intended to describe basic unit characteristics. The parameters listed are assumed to be independent of the selected output mode. If this is not the case, or if the information is not applicable to the device, an explanation should be provided. If a specific parameter is not applicable (N/A), this should be noted.

{6}------------------------------------------------

Table 3: Output Specifications
An output mode is defined (for reporting purposes) as aversion of a waveform produced by the unit. For example,biphasic symmetrical, biphasic asymmetrical, andmonophasic would all be considered separate outputmodes. A copy of the following information should becompleted for each output mode. If a specific parameter isnot applicable (N/A), this should be noted.
Unique output mode.No electrical output delivered to the body for this EMStechnology
CharacteristicsBios DevicePredicate DeviceNotes
Waveform (e.g.,pulsed monophasic,biphasic)BiphasicBiphasicN/A
Shape (e.g.,rectangular, spike,rectified sinusoidal)SinusoidalSinusoidalN/A
Maximum OutputVoltage (specify units)N/AN/ANo electrodes.Applicators arenot connectedto patient.
Maximum OutputCurrent (specify units)N/AN/ANo electrodes.Applicators arenot connectedto patient.
Pulse Width (specifyunits)Large HP: 280 ± 20% µsBTL 299-6 applicator: 280 ± 20% µsN/A
Small HP: 190 ± 20% µsBTL 299-7 applicator: 190 ± 20% µsN/A
Frequency (Hz)1-150 Hz1-150 HzN/A
For interferentialmodes only:- Beat Frequency (Hz)N/AN/AN/A
For multiphasicwaveforms only:- Symmetrical phases?- Phase Duration(include units)(state range, ifapplicable)(both phases, ifasymmetrical)YesYesN/A
Net Charge (mC per pulse)
Net Charge (mC per pulse)N/AN/ANo electrodes.Applicators are not connected to patient.
Maximum Phase Charge, (mC)N/AN/ANo electrodes.Applicators are not connected to patient.
Maximum Current Density (mA/cm²)N/AN/ANo electrodes.Applicators are not connected to patient.
Maximum Average CurrentN/AN/ANo electrodes.Applicators are not connected to patient.
Maximum Power Density (W/cm²) (using smallest electrode conductive surface area)N/AN/ANo electrodes.Applicators are not connected to patient.
Burst Mode (i.e., pulse trains)a. Pulses per burstb. Bursts per secondc. Burst duration (seconds)d. Duty Cycle [Line (b) x Line (c)]N/AN/AN/A
ON Time (seconds)N/AN/AN/A
OFF Time (seconds)N/AN/AN/A
Additional Features (if applicable)N/AN/AN/A

{7}------------------------------------------------

{8}------------------------------------------------

Performance Data

Electrical safety and electro-magnetic compatibility

The NuEra Tight Family, EMS Model, has been tested and is in compliance with:

  • . IEC 60601-1; Medical Electrical Equipment - Part 1: General Requirements For Basic Safety And Essential Performance;
  • . IEC 60601-1-2; Medical Electrical Equipment - Part 1-2: General Requirements For Basic Safety And Essential Performance - Collateral Standard: Electromagnetic Disturbances - Requirements And Tests;
  • IEC 60601-1-6; Medical Electrical Equipment Part 1-6: General Requirements For Basic Safety And ● Essential Performance - Collateral Standard: Usability;
  • IEC 60601-2-10/A1; Medical Electrical Equipment - Part 2-10: Particular Requirements For The Basic Safety And Essential Performance Of Nerve And Muscle Stimulators;
  • IEC 62304; Medical Device - Software Life Cycle Processes;
  • ISO 14971; Medical Devices Application Of Risk Management To Medical Devices .

Software Verification and Validation

In addition to the electrical safety testing performed, software verification was conducted to FDA regulations, standards and guidance document requirements. The results of this testing conclude the software has met these requirements. Design verification was also performed on the NuEra Tight Family, EMS Model, in compliance with internal design control procedures. The results of this testing conclude the NuEra Tight Family, EMS Model, is determined to be safe and effective.

Functional Testing

Functional tests have been performed to confirm that the performance of the NuEra Tight Family, EMS Model, devices are aligned with the device technical specifications.

Biocompatibility

Based on the type and duration of body contact, existing biocompatibility data has been assessed in accordance with ISO 10993-1:2018 (FDA standards recognition # 2-258) and FDA guidance document 'Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process": Guidance for Industry and Food and Drug Administration Staff', 16 June 2016.

The NuEra Tight Family, EMS Model, has no contact with the skin of the treated patients.

Conclusion

Based upon the indications for use and known technical information provided in this pre-market notification, the NuEra Tight Family, EMS Model, devices has been shown to be substantially equivalent to currently marketed predicate and reference devices. Any differences are considered minor and do not raise new issues of the safety and effectiveness of the NuEra Tight Family, EMS Model, devices when compared to the predicate devices.

§ 890.5850 Powered muscle stimulator.

(a)
Identification. A powered muscle stimulator is an electrically powered device intended for medical purposes that repeatedly contracts muscles by passing electrical currents through electrodes contacting the affected body area.(b)
Classification. Class II (performance standards).